drugset / Trial / NCT02410356
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study assesses the safety and tolerability of weekly TV-1106 compared to daily rhGH in adults with GHD who have previously been treated with rhGH.
Timeline
- Start
- 2015-04-30
- Primary completion
- 2016-02-29
- Completion
- 2016-04-30
Outcome
Outcome not reported
Stopped (Business): “Business decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALBUSOMATROPIN | Protein / enzyme biologic | — | Other |
| Comparator | dGH | Unknown | — | Other |